Speaker illustration

Professor Jun Zhu

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease

Date: 14 April 2020

Journal: Cardiovascular Research

Thumbnail

ESC 365 is supported by